Flurothyl

Last updated
Flurothyl
Flurothyl.svg
Clinical data
Other namesHexafluorodiethyl ether
ATC code
  • None
Identifiers
  • 2,2-Oxybis(1,1,1-trifluoroethane)
    or
    Bis(2,2,2-trifluoroethyl) ether
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard 100.155.160 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C4H4F6O
Molar mass 182.064 g·mol−1
3D model (JSmol)
Density 1.404 g/cm3 g/cm3
Boiling point 62 to 63 °C (144 to 145 °F)
  • C(C(F)(F)F)OCC(F)(F)F
  • InChI=1S/C4H4F6O/c5-3(6,7)1-11-2-4(8,9)10/h1-2H2 X mark.svgN
  • Key:KGPPDNUWZNWPSI-UHFFFAOYSA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Flurothyl (Indoklon) (IUPAC names: 1,1,1-trifluoro-2-(2,2,2-trifluoroethoxy)ethane or bis(2,2,2-trifluoroethyl) ether) is a volatile liquid drug from the halogenated ether family, related to inhaled anaesthetic agents such as diethyl ether, but having the opposite effects, acting as a stimulant and convulsant. [1] A clear and stable liquid, it has a mild ethereal odor whose vapors are non-flammable. It is excreted from the body by the lungs in an unchanged state. [2] [3] [4]

Contents

Several compounds related to the halogenated ether anesthetics have similar convulsant effects rather than producing sedation, and this has been helpful in studying the mechanism of action of these drugs. [5] [6] [7]

Currently, the main uses of flurothyl are:

(1) scientific research for inducing seizures in laboratory animals; [8]

(2) as an additive in lithium-ion batteries. [9]

Research into psychiatric treatment

Flurothyl was at one time studied in psychiatric medicine for shock therapy, in a similar manner to other convulsant drugs such as pentetrazol, as an alternative to electroconvulsive therapy (ECT). [10] [11] This use has now been discontinued.

In 1953, the Maryland pharmacologist J. C. Krantz experimented with flurothyl to induce seizures in psychiatric patients as an alternative to ECT. Flurothyl was injected into a plastic container in a tight fitting face mask. The patient inhaled a mixture of vapor and air, and expired air was forced into a charcoal adsorbent via a one-way valve. Oxygen was administered simultaneously. Flurothyl inhalations were first conducted without sedation or muscle paralysis. [12] [13] Premedication with pentothal and succinylcholine chloride, as is customary in ECT, was tested and found safe. [14]

Four random assignment treatment studies found the clinical results for flurothyl to be as effective as those of ECT. [15] [16] [17] [18] Flurothyl treatments were administered on the same schedules as ECT. In some patients who had not responded to ECT, flurothyl treatment produced improvement. [19]

The flurothyl treated patients showed less amnesia and confusion during the course of treatment with better patient acceptance. A detailed study comparing flurothyl and ECT in patients with severe endogenous depression, reported the degree of anterograde amnesia to be similar, but the degree of retrograde amnesia was much lower after flurothyl. [18] Psychological tests showed memory impairments at the fourth week of treatment, and memory improvement two weeks after the last treatment, with no measurable differences between the treatments.

Equal degrees of EEG slow wave increases were recorded in flurothyl and electrical induced seizures. [20] Oximetric and ECG studies showed comparable heart rate increases with occasional rhythmic irregularities. [16]

Flurothyl induced seizures were deemed clinically equal to electrical seizures with lesser effects on cognition and memory. An editorial in the Journal of the American Medical Association in 1966 encouraged its use. [21]

An injectable form of flurothyl was formulated. [22] The clinical results were the same as with inhaled flurothyl. [23]

Mechanism of Action

The convulsant properties of flurothyl pose a challenge to unifying theories of general anesthetics such as the Meyer-Overton hypothesis (see Theories of general anaesthetic action). [24] [25] A variety of halogenated ethers (e.g., isoflurane, sevoflurane) and diethyl ether itself are general anesthetics, and flurothyl is a substituted diethyl ether. Even more strikingly, a structural isomer of flurothyl known as isoflurothyl (1,1,1,3,3,3-hexafluoro-2-methoxypropane) induces general anesthesia and not convulsions in mice and dogs. [26] Isoflurothyl differs from the widely used inhalational anesthetic sevoflurane by only a single fluorine atom (sevoflurane has an additional fluorine on the methyl group).

A molecular explanation for the difference between flurothyl and isoflurothyl was provided by electrophysiology studies that showed flurothyl was an antagonist (blocker) of neuronal GABAA receptors and had no effect on neuronal glycine receptors. [27] This receptor selectivity resembles that of the well-characterized GABAA receptor antagonist picrotoxin. Studies using recombinant GABAA and glycine receptors confirmed this activity profile and further showed that isoflurothyl behaved similar to other ether anesthetics in acting as a positive allosteric modulator of GABAA and glycine receptors. [28] There is some evidence that flurothyl may actually possess general anesthetic properties at high concentrations that are masked by the more potent convulsant action. [26]

See also

Related Research Articles

<span class="mw-page-title-main">Ketamine</span> Dissociative medication

Ketamine is a dissociative anesthetic used medically for induction and maintenance of anesthesia. It is also used as a recreational drug. It is one of the safest anesthetics, as, in contrast with opiates, ether, and propofol, it suppresses neither respiration nor heart rate. Ketamine is a novel compound, derived from PCP, created in pursuit of a safer anesthetic with similar characteristics. Ketamine is also used for acute pain management.

<span class="mw-page-title-main">Isoflurane</span> General anaesthetic given via inhalation

Isoflurane, sold under the brand name Forane among others, is a general anesthetic. It can be used to start or maintain anesthesia; however, other medications are often used to start anesthesia rather than isoflurane, due to airway irritation with isoflurane. Isoflurane is given via inhalation.

<span class="mw-page-title-main">Sevoflurane</span> Inhalational anaesthetic

Sevoflurane, sold under the brand name Sevorane, among others, is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset. While its offset may be faster than agents other than desflurane in a few circumstances, its offset is more often similar to that of the much older agent isoflurane. While sevoflurane is only half as soluble as isoflurane in blood, the tissue blood partition coefficients of isoflurane and sevoflurane are quite similar. For example, in the muscle group: isoflurane 2.62 vs. sevoflurane 2.57. In the fat group: isoflurane 52 vs. sevoflurane 50. As a result, the longer the case, the more similar will be the emergence times for sevoflurane and isoflurane.

<span class="mw-page-title-main">Theories of general anaesthetic action</span>

A general anaesthetic is a drug that brings about a reversible loss of consciousness. These drugs are generally administered by an anaesthetist/anesthesiologist in order to induce or maintain general anaesthesia to facilitate surgery.

<span class="mw-page-title-main">Desflurane</span> Chemical compound

Desflurane (1,2,2,2-tetrafluoroethyl difluoromethyl ether) is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.

<span class="mw-page-title-main">Epidural administration</span> Medication injected into the epidural space of the spine

Epidural administration is a method of medication administration in which a medicine is injected into the epidural space around the spinal cord. The epidural route is used by physicians and nurse anesthetists to administer local anesthetic agents, analgesics, diagnostic medicines such as radiocontrast agents, and other medicines such as glucocorticoids. Epidural administration involves the placement of a catheter into the epidural space, which may remain in place for the duration of the treatment. The technique of intentional epidural administration of medication was first described in 1921 by Spanish military surgeon Fidel Pagés. In the United States, over 50% of childbirths involve the use of epidural anesthesia.

<span class="mw-page-title-main">Chloralose</span> Chemical compound

Chloralose is an avicide, and a rodenticide used to kill mice in temperatures below 15 °C. It is also widely used in neuroscience and veterinary medicine as an anesthetic and sedative. Either alone or in combination, such as with urethane, it is used for long-lasting, but light anesthesia.

<span class="mw-page-title-main">Enflurane</span> Chemical compound

Enflurane is a halogenated ether. Developed by Ross Terrell in 1963, it was first used clinically in 1966. It was increasingly used for inhalational anesthesia during the 1970s and 1980s but is no longer in common use.

Minimum alveolar concentration or MAC is the concentration, often expressed as a percentage by volume, of a vapour in the alveoli of the lungs that is needed to prevent movement in 50% of subjects in response to surgical (pain) stimulus. MAC is used to compare the strengths, or potency, of anaesthetic vapours. The concept of MAC was first introduced in 1965.

A post-anesthesia care unit, often abbreviated PACU and sometimes referred to as post-anesthesia recovery or PAR, or simply Recovery, is a vital part of hospitals, ambulatory care centers, and other medical facilities. Patients who received general anesthesia, regional anesthesia, or local anesthesia are transferred from the operating room suites to the recovery area. The patients are monitored typically by anesthesiologists, certified registered nurse anesthetists, and other medical staff. Providers follow a standardized handoff to the medical PACU staff that includes, which medications were given in the operating room suites, how hemodynamics were during the procedures, and what is expected for their recovery. After initial assessment and stabilization, patients are monitored for any potential complications, until the patient is transferred back to their hospital rooms.

<span class="mw-page-title-main">Methoxyflurane</span> Chemical compound

Methoxyflurane, sold under the brand name Penthrox among others, is an inhaled medication primarily used to reduce pain following trauma. It may also be used for short episodes of pain as a result of medical procedures. Onset of pain relief is rapid and of a short duration. Use is only recommended with direct medical supervision.

<span class="mw-page-title-main">NMDA receptor antagonist</span> Class of anesthetics

NMDA receptor antagonists are a class of drugs that work to antagonize, or inhibit the action of, the N-Methyl-D-aspartate receptor (NMDAR). They are commonly used as anesthetics for animals and humans; the state of anesthesia they induce is referred to as dissociative anesthesia.

μ-opioid receptor Protein-coding gene in the species Homo sapiens, named for its ligand morphine

The μ-opioid receptors (MOR) are a class of opioid receptors with a high affinity for enkephalins and beta-endorphin, but a low affinity for dynorphins. They are also referred to as μ(mu)-opioid peptide (MOP) receptors. The prototypical μ-opioid receptor agonist is morphine, the primary psychoactive alkaloid in opium and for which the receptor was named, with mu being the Greek letter m. It is an inhibitory G-protein coupled receptor that activates the Gi alpha subunit, inhibiting adenylate cyclase activity, lowering cAMP levels.

<span class="mw-page-title-main">Etoxadrol</span> Chemical compound

Etoxadrol (CL-1848C) is a dissociative anaesthetic drug that has been found to be an NMDA antagonist and produce similar effects to PCP in animals. Etoxadrol, along with another related drug dexoxadrol, were developed as analgesics for use in humans, but development was discontinued in the late 1970s after patients reported side effects such as nightmares and hallucinations.

Guedel's classification is a means of assessing of depth of general anesthesia introduced by Arthur Ernest Guedel (1883-1956) in 1920.

A convulsant is a drug which induces convulsions and/or epileptic seizures, the opposite of an anticonvulsant. These drugs generally act as stimulants at low doses, but are not used for this purpose due to the risk of convulsions and consequent excitotoxicity. Most convulsants are antagonists at either the GABAA or glycine receptors, or ionotropic glutamate receptor agonists. Many other drugs may cause convulsions as a side effect at high doses but only drugs whose primary action is to cause convulsions are known as convulsants. Nerve agents such as sarin, which were developed as chemical weapons, produce convulsions as a major part of their toxidrome, but also produce a number of other effects in the body and are usually classified separately. Dieldrin which was developed as an insecticide blocks chloride influx into the neurons causing hyperexcitability of the CNS and convulsions. The Irwin observation test and other studies that record clinical signs are used to test the potential for a drug to induce convulsions. Camphor, and other terpenes given to children with colds can act as convulsants in children who have had febrile seizures.

Magnetic seizure therapy (MST) is a proposed form of electrotherapy and electrical brain stimulation. It is currently being investigated for the treatment of major depressive disorder, treatment-resistant depression (TRD), bipolar depression, schizophrenia and obsessive-compulsive disorder. MST is stated to work by inducing seizures via magnetic fields, in contrast to ECT which does so using alternating electric currents. Additionally, MST works in a more concentrated fashion than ECT, thus able to create a seizure with less of a total electric charge. In contrast to (r)TMS, the stimulation rates are higher resulting in more energy transfer. Currently it is thought that MST works in patients with major depressive disorder by activating the connection between the subgenual anterior cingulate cortex and the parietal cortex.

In the study of inhaled anesthetics, the concentration effect is the increase in the rate that the Fa /Fi ratio rises as the alveolar concentration of that gas is increased. In simple terms, the higher the concentration of gas administered, the faster the alveolar concentration of that gas approaches the inspired concentration. In modern practice it is only relevant for nitrous oxide since other inhaled anesthetics are delivered at much lower concentrations due to their higher potency.

<span class="mw-page-title-main">History of neuraxial anesthesia</span>

The history of neuraxial anesthesia goes back to 1885.

<span class="mw-page-title-main">Isoflurothyl</span> Chemical compound

Isoflurothyl is a fluorinated ether related to the inhalational convulsant flurothyl. It is the structural isomer of flurothyl. Unlike flurothyl, however, isoflurothyl is a general anesthetic.

References

  1. ↑ Rose L, Watson A (July 1967). "Flurothyl (Indoklon). Experience with an inhalational convulsant agent". Anaesthesia. 22 (3): 425–34. doi: 10.1111/j.1365-2044.1967.tb02765.x . PMID   4951597. S2CID   5714209.
  2. ↑ Karliner W, Padula LJ (1962). "Further clinical studies of hexafluorodiethyl ether convulsive treatments". Journal of Neuropsychiatry. 3: 159–62. PMID   14453985.
  3. ↑ Speers L, Neeley AH (February 1963). "The synthesis, chemical and physical properties of Indoklon". Journal of Neuropsychiatry. 4: 153–6. PMID   13989984.
  4. ↑ Krantz JC, Loecher CK (1967). "Anesthesia LXX: effect of inert fluorinated agents on fluroxene and flurothyl". Anesthesia and Analgesia. 46 (3): 271–4. doi:10.1213/00000539-196705000-00001. PMID   4381591. S2CID   36367759.
  5. ↑ Koblin DD, Chortkoff BS, Laster MJ, Eger EI, Halsey MJ, Ionescu P (December 1994). "Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis". Anesthesia and Analgesia. 79 (6): 1043–8. doi: 10.1213/00000539-199412000-00004 . PMID   7978424.
  6. ↑ Koblin DD, Laster MJ, Ionescu P, Gong D, Eger EI, Halsey MJ, Hudlicky T (May 1999). "Polyhalogenated methyl ethyl ethers: solubilities and anesthetic properties". Anesthesia and Analgesia. 88 (5): 1161–7. doi: 10.1213/00000539-199905000-00036 . PMID   10320188.
  7. ↑ Eger EI, Halsey MJ, Harris RA, Koblin DD, Pohorille A, Sewell JC, et al. (June 1999). "Hypothesis: volatile anesthetics produce immobility by acting on two sites approximately five carbon atoms apart". Anesthesia and Analgesia. 88 (6): 1395–400. doi: 10.1213/00000539-199906000-00036 . PMID   10357351.
  8. ↑ Hashimoto Y, Araki H, Suemaru K, Gomita Y (May 2006). "Effects of drugs acting on the GABA-benzodiazepine receptor complex on flurothyl-induced seizures in Mongolian gerbils". European Journal of Pharmacology. 536 (3): 241–7. doi:10.1016/j.ejphar.2006.02.036. PMID   16581068.
  9. ↑ (76) Jiang, L. L.; Yan, C.; Yao, Y. X.; Cai, W.; Huang, J. Q.; Zhang, Q. Inhibiting Solvent Cointercalation in a Graphite Anode by a Localized High-Concentration Electrolyte in Fast-Charging Batteries. Angew. Chem., Int. Ed. 2021, 60, 3402−3406.
  10. ↑ "A convulsant agent for psychiatric use. Flurothyl (Indoklon)". JAMA. 196 (1): 29–30. April 1966. doi:10.1001/jama.196.1.29. PMID   4379572.
  11. ↑ Small JG, Small IF, Sharpley P, Moore DF (July 1968). "A double-blind comparative evaluation of flurothyl and ECT". Archives of General Psychiatry. 19 (1): 79–86. doi:10.1001/archpsyc.1968.01740070081012. PMID   5658383.
  12. ↑ Esquibel AJ, Krantz JC, Truitt EB, Ling AS, Kurland AA (June 1958). "Hexafluorodiethyl ether (indoklon): its use as a convulsant in psychiatric treatment". The Journal of Nervous and Mental Disease. 126 (6): 530–4. doi:10.1097/00005053-195806000-00004. PMID   13564231. S2CID   2650010.
  13. ↑ Krantz JC, Esquibel A, Truitt EB, Ling AS, Kurland AA (March 1958). "Hexafluorodiethyl ether (indoklon); an inhalant convulsant; its use in psychiatric treatment". Journal of the American Medical Association. 166 (13): 1555–62. doi:10.1001/jama.1958.02990130015004. PMID   13513394.
  14. ↑ Karliner WJ, Padina LJ (1959). "Indoklon combined with Pentothal and Anectine". Am. J. Psychiatry. 115 (11): 1041–1042. doi:10.1176/ajp.115.11.1041.
  15. ↑ Fink M, Kahn RL, Karp E, Pollack M, Green MA, Alan B, Efkowits HJ (March 1961). "Inhalant-induced convulsions. Significance for the theory of the convulsive therapy process". Archives of General Psychiatry. 4 (3): 259–66. doi:10.1001/archpsyc.1961.01710090045006. PMID   13699611.
  16. 1 2 Kurland AA, Hanlon TE, Esquibel AJ, Krantz JC, Sheets CS (July 1959). "A comparative study of hexafluorodiethyl ether (indoklon) and electroconvulsive therapy". The Journal of Nervous and Mental Disease. 129: 95–8. doi:10.1097/00005053-195907000-00016. PMID   14412877.
  17. ↑ Small JG, Small IF, Sharpley P, Moore DF (July 1968). "A double-blind comparative evaluation of flurothyl and ECT". Archives of General Psychiatry. 19 (1): 79–86. doi:10.1001/archpsyc.1968.01740070081012. PMID   5658383.
  18. 1 2 Laurell B (1970). "Flurothyl convulsive therapy". Acta Psychiatrica Scandinavica. Supplementum. 213: 1–79. PMID   4394881.
  19. ↑ Karliner W, Padula LJ (1960). "The use of hexafluorodiethyl ether in psychiatric treatment". Journal of Neuropsychiatry. 2: 67–70. PMID   13751512.
  20. ↑ Fink M (1979). Convulsive Therapy: Theory and Practice. New York: Raven Press.
  21. ↑ "A convulsant agent for psychiatric use. Flurothyl (Indoklon)". JAMA. 196 (1): 29–30. April 1966. doi:10.1001/jama.196.1.29. PMID   4379572.
  22. ↑ Krantz JC, Manchey LL, Truitt EB, Ling AS, Kurland AA (July 1959). "The availability of hexafluorodiethyl ether by intravenous injection as a convulsant in psychiatric treatment". The Journal of Nervous and Mental Disease. 129: 92–4. doi:10.1097/00005053-195907000-00015. PMID   14411701.
  23. ↑ Karliner W (February 1963). "Clinical experiences with intravenous Indoklon: a new convulsant drug". Journal of Neuropsychiatry. 4: 184–9. PMID   13962526.
  24. ↑ Koblin DD, Chortkoff BS, Laster MJ, Eger EI, Halsey MJ, Ionescu P (December 1994). "Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis". Anesthesia and Analgesia. 79 (6): 1043–8. doi: 10.1213/00000539-199412000-00004 . PMID   7978424.
  25. ↑ Krasowski MD (July 2003). "Contradicting a unitary theory of general anesthetic action: a history of three compounds from 1901 to 2001". Bulletin of Anesthesia History. 21 (3): 1, 4–8, 21 passim. doi:10.1016/s1522-8649(03)50031-2. PMC   2701367 . PMID   17494361.
  26. 1 2 Koblin DD, Eger EI, Johnson BH, Collins P, Terrell RC, Speers L (July 1981). "Are convulsant gases also anesthetics?". Anesthesia and Analgesia. 60 (7): 464–70. doi: 10.1213/00000539-198107000-00002 . PMID   7195661.
  27. ↑ Wakamori M, Ikemoto Y, Akaike N (December 1991). "Effects of two volatile anesthetics and a volatile convulsant on the excitatory and inhibitory amino acid responses in dissociated CNS neurons of the rat". Journal of Neurophysiology. 66 (6): 2014–21. doi:10.1152/jn.1991.66.6.2014. PMID   1667416.
  28. ↑ Krasowski MD (April 2000). "Differential modulatory actions of the volatile convulsant flurothyl and its anesthetic isomer at inhibitory ligand-gated ion channels". Neuropharmacology. 39 (7): 1168–83. doi:10.1016/s0028-3908(99)00221-x. PMC   2846390 . PMID   10760360.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.